<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04621747</url>
  </required_header>
  <id_info>
    <org_study_id>RBHP 2020 DUALE</org_study_id>
    <nct_id>NCT04621747</nct_id>
  </id_info>
  <brief_title>Trial Investigating the Characteristics of Knismesis - a Lever to Explore Allodynia in Neuropathic Pain</brief_title>
  <acronym>TICKLE</acronym>
  <official_title>Trial Investigating the Characteristics of Knismesis - a Lever to Explore Allodynia in Neuropathic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NEURO-DOL (UMR 1107 INSERM / UCA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Also known as a &quot;moving itch&quot;, knismesis is a mildly annoying sensation caused by a light&#xD;
      movement on the skin, such as from a crawling insect. Its underlying mechanism rely on&#xD;
      spatial summation, i.e. amplification of the signal due to summation of stimulated fields,&#xD;
      like it is for dynamic allodynia in neuropathic pain. This physiological study aims at&#xD;
      determining the physical factors of the cutaneous stimulation inducing knismesis as well as&#xD;
      the effect of confounding factors. The main area of exploration will be the back, because of&#xD;
      its size and the possibility to blind the participant. The information collected, along with&#xD;
      animal data in surrogate models, would help to better understand neuropathic pain in the&#xD;
      future.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a physiological proof-of-concept, also aiming to validate a functional exploration&#xD;
      model in healthy volunteers. Each participant will undergo a battery if psychometric then&#xD;
      psychophysics tests, presented sequentially. However, most of the main study tests&#xD;
      (knismesis) will be admistered in a random order (crossover). The primary endpoint is to&#xD;
      characterise, in the healthy human, the physical determinants of the cutaneous stimulation&#xD;
      inducing knismesis: length of the pathway, speed, direction, intensity, continuity break of&#xD;
      the contact, hairiness, body site, or distraction by other cutaneous stimuli. The secondary&#xD;
      endpoint is to study the relationship between the individual sensitivity to spatial summation&#xD;
      (knismesis) and other individual sensitivities or profiles.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intensity of annoying sensation</measure>
    <time_frame>Day 1</time_frame>
    <description>After training, the annoying sensation is expressed by the subject through a handgrip dynamometer (Biopac systems). The signal will be treated and converted into area-under-curve response (Dualé C et al., Reg Anesth Pain Med 2011; 36:110-115).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intensity of annoying sensation</measure>
    <time_frame>Day 8</time_frame>
    <description>After training, the annoying sensation is expressed by the subject through a handgrip dynamometer (Biopac systems). The signal will be treated and converted into area-under-curve response (Dualé C et al., Reg Anesth Pain Med 2011; 36:110-115).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscular aversive response.</measure>
    <time_frame>Day 1, Day 8</time_frame>
    <description>The muscular aversive response will be assessed by surface electromyography through paraspinal contact electrodes (Biopac systems).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>healthy volunteers aged 18-35, balanced sex ratio, all of them undergoing the same battery of psychophysical explorations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Battery of neurophysiological explorations</intervention_name>
    <description>Visit 1: Biometry collection: gender, age, weight, height, eye colour.&#xD;
Questionnaires : the State and Trait Anxiety Inventory and the Pain Sensitivity&#xD;
Threshold of unpleasant light brightness, mechanical sensitivity threshold (von Frey hair).&#xD;
Training to estimate unpleasantness Under nociceptive and tickling stimuli, to use the handgrip.&#xD;
Mechanical pain threshold (electronic von Frey), heat pain threshold (Medoc Pathway).&#xD;
48 stimulations applied to the back skin, following a predetermined plan with 12 different pathways, imbricated with 4 different speeds of movement.&#xD;
Visit 2 (1 to 8 days later) :&#xD;
42 stimulations applied to the back skin, to test the effect of stimulation intensity, the side of application, continuity break of the contact, and distraction by other cutaneous stimuli. The stimuli will follow the best paradigm as identified at the previous visit.&#xD;
12 stimulations applied to forearm, cheeks, lower limbs, also testing the effect of hairiness.</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Ability to answer French questionnaires.&#xD;
&#xD;
        · BMI between 19 and 30 kg/m2 at inclusion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or breastfeeding.&#xD;
&#xD;
          -  Natural intolerance to tickling.&#xD;
&#xD;
          -  Any cutaneous, ocular or neurological disease contraindicating the psychophysical&#xD;
             tests.&#xD;
&#xD;
          -  Any disease or medical history that could expose the subject to unacceptable risk&#xD;
             during the study.&#xD;
&#xD;
          -  Any medication intake within 7 days before testing.&#xD;
&#xD;
          -  History of drug or alcohol abuse.&#xD;
&#xD;
          -  Involvement in another concomitant research protocol.&#xD;
&#xD;
          -  Major dorsal hairiness.&#xD;
&#xD;
          -  Inability to undergo the tests.&#xD;
&#xD;
          -  Legal protection.&#xD;
&#xD;
          -  Concomitant involvement in another clinical research.&#xD;
&#xD;
          -  Refusal to participate.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lise Laclautre</last_name>
    <phone>0473754963</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital, Clermont Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <state>Auvergne</state>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>lise laclautre</last_name>
      <phone>0473754963</phone>
      <email>promo_interne_drci@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Christian Dualé</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 2, 2020</study_first_submitted>
  <study_first_submitted_qc>November 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 6, 2020</last_update_submitted>
  <last_update_submitted_qc>November 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurophysiology</keyword>
  <keyword>Psychophysics</keyword>
  <keyword>Sensory thresholds</keyword>
  <keyword>Neurons</keyword>
  <keyword>Pain, neuropathic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

